Showing results (21-30 of 267) with videos related to
Sort By:
Pageof 27
Clinical and Experimental Immunology|August 1, 1996
Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)M Shindo, G E Mullin, L Braun-Elwert, et al.The American Journal of Physiology|June 1, 1988
Determination of sulfobromophthalein excretion in rabbitsJ M Quale, N V Bergasa, L J MandelJournal of Clinical Gastroenterology|September 9, 1999
Atrophy of the left lobe of the liver and anomalous hepatic vessel in a patient with Yunis-Varon syndromeJ Christie, S Sacks, D Decorato, et al.Peptides|September 30, 1999
The opioid peptide analog D-Ala2-Met-enkephalinamide decreases bile flow by a central mechanismN V Bergasa, J Zhou, J Ravi, et al.The American Journal of Gastroenterology|October 1, 1996
Intractable cough and abnormal pulmonary function in benign recurrent intrahepatic cholestasisR Chatila, N V Bergasa, S Lagarde, et al.Hepatology (Baltimore, Md.)|March 21, 1998
Open-label trial of oral nalmefene therapy for the pruritus of cholestasisN V Bergasa, J M Schmitt, T L Talbot, et al.Annals of Internal Medicine|August 1, 1995
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trialN V Bergasa, D W Alling, T L Talbot, et al.The American Journal of Medicine|November 1, 1988
Clinical significance and pathogenesis of hyperbilirubinemia associated with Staphylococcus aureus septicemiaJ M Quale, L J Mandel, N V Bergasa, et al.Gastroenterology|February 1, 1992
A controlled trial of naloxone infusions for the pruritus of chronic cholestasisN V Bergasa, T L Talbot, D W Alling, et al.The American Journal of Gastroenterology|May 26, 2001
Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver diseaseN V Bergasa, M J Link, M Keogh, et al.Pageof 27